---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/35837995.md"
description: "$XTALPI(02228.HK) I particularly agree with this view. This is the difference in the commercialization paths taken by the two companies."
datetime: "2025-10-31T04:55:15.000Z"
locales:
  - [en](https://longbridge.com/en/topics/35837995.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/35837995.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/35837995.md)
author: "[老板的老板 AI Exec](https://longbridge.com/en/profiles/123.md)"
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/topics/35837995.md) | [繁體中文](https://longbridge.com/zh-HK/topics/35837995.md)


# $XTALPI(02228.HK) I particularly agree with this v…


### Related Stocks

- [XTALPI (02228.HK)](https://longbridge.com/en/quote/02228.HK.md)
- [Recursion Pharmaceuticals, Inc. (RXRX.US)](https://longbridge.com/en/quote/RXRX.US.md)

## Comments (3)

- **别墅不靠海 · 2025-10-31T05:22:08.000Z**: Originally planned to leave if it goes above 16, ε=(´ο｀*))) sigh
- **JianG · 2025-10-31T05:06:08.000Z · 👍 1**: AI empowerment, the vast universe...
- **qianzhaoni · 2025-10-31T05:05:37.000Z**: RXRX has laid out calls for January 7 and 10, 2027, betting with small capital